| [1] |
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry[J].Circ Res,2003,92(8):827-839.
|
| [2] |
Guo M, Cox B, Mahale S, et al. Pre-ischemic exerei reduces matrix metalloproteinase-9 expression and ameliorates bloodbrain barrier dysfunetion in stroke[J]. Neuroscience, 2008, 151(2):340-351.
|
| [3] |
Lauer D, Slavic S, Sommerfeld M, et al. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/Matrix metalloproteinase- 9 axis and transforming growth factor β1 in the rat heart[J].Hypertension,2014,63(3):e60-e67.
|
| [4] |
Malemud CJ. Matrix metalloproteinases(MMPs) in healthand disease:an overview[J].Front Biosci,2006,11(1):1696-1701.
|
| [5] |
Singh A, Maurya OP, Jagannadhan MV, et al. Matrix metalloproteinases (MMP-2 and MMP-9) activity in corneal ulcer and ocular surface disorders determined by gelatin zymography[J].J Ocul Biol Dis Infor,2012,5(2):31-35.
|
| [6] |
Pfefferkom T, Rosenberg GA. Closure of the blood- brain barrier by matrix metalloproteinase inhibition reduces rtPAmediated mortality in cerebral ischemia with delayed reperfusion[J].Stroke,2003,34(8):2025-2030.
|
| [7] |
Lukaszewicz-Zajac M, Mroczko B, Kornhuber J, et al. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs)in the tumors of central nervous system (CNS)[J]. J Neural Transm,2013,121(5):469-477.
|
| [8] |
Rosenberg GA. Matrix metalloproteinase in neuroinflammation[J].Glia,2002,39(3):279-291.
|
| [9] |
Fater M, Stroick M, Griebe M, et al. Matrix metalloproteinases in cerebrovascular diseases[J]. Cerebrovasc Dis, 2005, 20(3):141-151.
|
| [10] |
Lee P, Kim J. Williams R. Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice[J].Exp Neurol,2012,234(1):50-61.
|
| [11] |
Suofu Y,Clark JF,Broderick JP,et al.Matrix metalloproteinase-2 or-9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion[J].Neuroscience,2012,212(6):180-189.
|
| [12] |
Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase- 9 gene knock- out on the proteolysis of bloodbrainbarrier and white matter components after cerebralischemia[J].J Neurosci,2001,21(19):7724-7732.
|
| [13] |
Vajtr D, Benada O. Correlation of ultrastructural changes of endothelial cells and astrocytes occurring during blood brain barrier damage after traumatic brain injury with biochemical markers of BBB leakage and inflammatory response[J].Physiol Res,2009,58(2):263-268.
|
| [14] |
Gursoy- Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and up-regulates MMP-9[J]. J Clin Invest,2004,113(10):1447-1455.
|
| [15] |
Kim GW, Gasche Y, Grzeschik S, et al. Neurodegeneration in striatum induced by the mitochondrial toxin3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption[J].J Neurosci,2003,23(25):8733-8742.
|
| [16] |
Mori T, Wang X, Aoki T, et al. Down regulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury[J].J Nerotrauma,2002,19(11):1411-1419.
|
| [17] |
Oppenheim HA,Lucero J,Guyot AC,et al.Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice[J].Part Fibre Toxicol,2013,10(12):62.
|
| [18] |
Gu Z, Kaul M, Yan B, et al. S- nitorsylation of matrix metalloproteinases signsling pathway to neuronal cell death[J].Science,2002,297(5584):1186-1190.
|
| [19] |
Lee JY, Lee HE, Kang SR, et al. Fluoxetine inhibits transient global ischemia- induced hippocampal neuronal death and memory impairment by preventing blood- brain barrier disruption[J].Neuropharmacology,2014,79(1):161-171.
|